Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

BACKGROUND: Patients with type II diabetes mellitus (DM) have an increased risk of adenomatous colorectal (CRC) polyps and CRC cancer. The use of the anti-hyperglycemic agent metformin is associated with a reduced incidence of cancer-related deaths. METHODS: We retrospectively evaluated the medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrett, C R, Hassabo, H M, Bhadkamkar, N A, Wen, S, Baladandayuthapani, V, Kee, B K, Eng, C, Hassan, M M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326682/
https://www.ncbi.nlm.nih.gov/pubmed/22421948
http://dx.doi.org/10.1038/bjc.2012.71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326682/
https://www.ncbi.nlm.nih.gov/pubmed/22421948
http://dx.doi.org/10.1038/bjc.2012.71

Ejemplares similares